Google News source Google Search article A recent study in Science found that bacteria, even those isolated from the soil, can be engineered to make specific components of vaccines.
And that means you could conceivably find a strain that can make vaccines, or vaccines that target specific pathogens, without ever having to inject them.
That’s because the proteins produced by the bacteria in vaccines are designed to bind to specific proteins.
They’re engineered to bind the particular protein of interest, and that binding will then make the vaccine immune to the particular disease the bacteria was designed to fight.
The proteins in the vaccine can then be transferred from the vaccine to the person taking it.
But what about when you’re taking a vaccine that doesn’t make you sick?
How about if you’re not sure how you’re going to get the vaccine?
How do you know you can trust the vaccine you’re about to take?
That’s the question scientists are trying to answer by looking for different proteins that can turn off specific genes in bacteria that might be helpful for the vaccine.
This research has been in the works for a while now, but it was first published in Science in February 2017.
A team led by scientists at the University of Maryland and Rutgers University in New Jersey looked at the genes that are turned off by a strain of Candida albicans, which is common in the soil.
The researchers found that when they used these bacteria as a model to investigate the effects of vaccines, the Candida was actually able to protect itself from the type of disease it was designed for.
So how does this work?
Researchers have been looking for genes that control how many times a particular strain of bacteria is made to attach to particular proteins.
When a bacterium is made by a designer to produce one particular protein, it will bind to that particular protein in order to make more of it.
As a result, the bacteria will produce more of that particular gene, which will turn off a gene that normally controls how many proteins a bacteria needs to make.
The researchers also found that the proteins that are made by the Candidactis are able to bind specific proteins that the bacteria itself has no need to make, so they’re able to make vaccines that are more effective at preventing disease in those who are infected.
The vaccines are more potent and more effective than ones that don’t target a specific disease.
“If you want to have a vaccine against Candida, you want the vaccine against the Candids,” said Dr. David Wessels, an immunologist at Rutgers University who wasn’t involved in the research.
“You want the vaccines against all of the pathogens that you can come up with.
If you’re trying to target a disease, the only way to do that is to have the vaccine specifically against a disease.”
The research is still very preliminary.
The scientists have not yet published their results in a peer-reviewed journal.
They hope to conduct further research in the future.
For more about the science behind vaccines, click here